A detailed history of Commerzbank Aktiengesellschaft transactions in Dexcom Inc stock. As of the latest transaction made, Commerzbank Aktiengesellschaft holds 1,791 shares of DXCM stock, worth $124,456. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,791
Previous 2,078 13.81%
Holding current value
$124,456
Previous $289,000 29.41%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$110.31 - $140.45 $31,658 - $40,309
-287 Reduced 13.81%
1,791 $204,000
Q1 2024

May 10, 2024

BUY
$114.22 - $140.1 $52,883 - $64,866
463 Added 28.67%
2,078 $289,000
Q4 2023

Feb 01, 2024

BUY
$75.49 - $124.16 $121,916 - $200,518
1,615 New
1,615 $201,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Commerzbank Aktiengesellschaft Portfolio

Follow Commerzbank Aktiengesellschaft and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

News

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.